Published in Med Clin (Barc) on October 13, 1990
GPR1 encodes a putative G protein-coupled receptor that associates with the Gpa2p Galpha subunit and functions in a Ras-independent pathway. EMBO J (1998) 2.37
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann Oncol (2007) 1.96
Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings. Am J Clin Pathol (2002) 1.72
Increased serum levels of CD44s and CD44v6 in patients with AIDS-related non-Hodgkin's lymphoma. AIDS (2000) 1.57
Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Haematologica (1999) 1.48
Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica (1998) 1.47
The quotient of number of nodes and tumour size (N/T) from primary breast cancer predicts the clinical course after diagnosis of distant relapse. Eur J Surg Oncol (2004) 1.44
Predictive modelling in hormone-refractory prostate cancer (HRPC). Clin Transl Oncol (2009) 1.40
[Experience with 150 subcutaneous venous reservoirs for venous access and infusion for the treatment of adult patients with oncologic and hematologic disorders and acquired immunodeficiency syndrome]. Med Clin (Barc) (1992) 1.40
[Lymphoma of the marginal zone of the spleen. A case study]. Med Clin (Barc) (1996) 1.39
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Res Treat (2012) 1.22
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol (2000) 1.21
Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol (1999) 1.17
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. Leukemia (2006) 1.13
Improvement of breast cancer relapse prediction in high risk intervals using artificial neural networks. Breast Cancer Res Treat (2005) 1.12
Massive tumor implantation in the endoscopic resected area in modified nephroureterectomy. J Urol (1997) 1.08
[Splenic lymphoma with circulating villous lymphocytes. Study of 6 patients]. Sangre (Barc) (1993) 1.08
[Primary gastrointestinal lymphomas: response to eradicative therapy and prognostic factors in 52 patients]. Med Clin (Barc) (1998) 1.07
ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats. Exp Neurol (2012) 1.06
Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant (1996) 1.05
Maintenance treatment in metastatic breast cancer. Expert Rev Anticancer Ther (2008) 1.04
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. J Clin Oncol (2000) 0.99
Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome. Am J Hematol (1993) 0.96
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol (2003) 0.94
Local recurrence of low rectal cancer after abdominoperineal and anterior resection. Br J Surg (1997) 0.93
CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease. Ann Hematol (2003) 0.93
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study. Ann Oncol (2010) 0.92
Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer (1992) 0.92
Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg (1996) 0.91
Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis (2010) 0.90
Acute promyelocytic leukemia in a HIV seropositive patient. Leuk Lymphoma (1997) 0.89
Liver retransplantation for alcoholic cirrhosis recurring within a 21-month period. Transpl Int (1996) 0.89
Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes. Leuk Lymphoma (1996) 0.89
Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation. Bone Marrow Transplant (2004) 0.88
Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol (1995) 0.87
The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders. Haematologica (1998) 0.87
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer. Eur J Cancer (2000) 0.85
International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients. Haematologica (1998) 0.85
Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol (1997) 0.84
Red cell distribution width, free erythrocyte protoporphyrin, and England-Fraser index in the differential diagnosis of microcytosis due to iron deficiency or beta-thalassemia trait. A study of 200 cases of microcytic anemia. Hematol Pathol (1991) 0.84
Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E. Nephrol Dial Transplant (2001) 0.83
Acute promyelocytic leukemia in a patient with idiopathic myelofibrosis. Leukemia (1999) 0.83
Elevated serum ferritin levels: associated diseases and clinical significance. Am J Med (1996) 0.83
Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer. Breast Cancer Res Treat (2001) 0.82
Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatment. Ann Oncol (2010) 0.82
Association of acromegaly and two malignancies: colorectal cancer and non-Hodgkin's lymphoma. Ann Oncol (1994) 0.81
Ectopic liver and hepatocarcinogenesis. Hepatology (1999) 0.81
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients. Leuk Res (2005) 0.81
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Ann Oncol (2012) 0.81
Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size. Leuk Res (2010) 0.81
Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer: a GEICAM-9801 phase II study. Breast Cancer Res Treat (2003) 0.81
Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transpl Int (1995) 0.80
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study). Med Mycol (2012) 0.80
Hemosiderin deposits confounds tracking of iron-oxide-labeled stem cells: an experimental study. Transplant Proc (2008) 0.80
Calcification of lymph node metastases from prostate carcinoma after hormonal treatment: a case report. Prostate (1997) 0.80
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. Br J Cancer (2013) 0.79
[Diagnostic and therapeutic strategy in injuries of the kidney. Apropos of a series of 248 cases]. Ann Urol (Paris) (1988) 0.79
Bilateral testicular germ cell tumours: a single hospital experience. Clin Transl Oncol (2010) 0.79
Prognosis of microinvasive breast carcinoma with negative axillary nodes in accordance with TNM classification criteria. Breast J (2010) 0.79
G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+. Bone Marrow Transplant (2006) 0.79
A dynamic analysis of the ventilatory response to carbon dioxide inhalation in man. J Physiol (1988) 0.79
Cystic smooth-muscle tumor of the liver and spleen associated with Epstein-Barr virus after renal transplantation. Am J Surg Pathol (1996) 0.79
Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer. Antimicrob Agents Chemother (2008) 0.78
[Pseudotumorous cardiac infiltration in a patient with acute monoblastic leukemia]. Med Clin (Barc) (1996) 0.78
Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer. Invest New Drugs (1992) 0.78
Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion. AIDS (1991) 0.78
Case report: incomplete septal cirrhosis with liver cell dysplasia. J Gastroenterol Hepatol (1997) 0.78
[Spontaneous rupture of the esophagus (Boerhaave syndrome) in a patient with scleroderma treated by continuous ambulatory peritoneal dialysis]. Rev Med Interne (1997) 0.78
[Spinal cord compression in non-Hodgkin's lymphoma. A study of 10 patients]. Med Clin (Barc) (1997) 0.77
A study of lymphocytic beta-glucuronidase in various benign and malignant lymphatic processes. Acta Haematol (1974) 0.77
Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation. Exp Hematol (1994) 0.77
[Hodgkin's disease in patients infected by the human immunodeficiency virus. Study of fifteen cases]. Med Clin (Barc) (2000) 0.77
Disseminated Mycobacterium avium infection after liver transplantation. Eur J Clin Microbiol Infect Dis (1998) 0.77
[The automatic determination of organic acids by potentiometry]. Bull Soc Chim Biol (Paris) (1968) 0.77
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer. Br J Cancer (2002) 0.77
E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience. Ann Oncol (2001) 0.77
[Automatic and simultaneous determination of amino acids and guanidines]. Bull Soc Chim Biol (Paris) (1970) 0.77
[Pneumonia in patients with chronic lymphocytic leukemia. Study of 30 episodes]. Med Clin (Barc) (2001) 0.77
Eosinophilic fasciitis and non-Hodgkin lymphoma. Eur J Haematol (1994) 0.77
Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study. J Clin Oncol (1997) 0.76
[Lactobacillus spp. bacteremia in a patient with neutropenia secondary to the treatment of acute leukemia]. Med Clin (Barc) (2001) 0.76
Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs (1992) 0.76
K+ channels expression in hypertension after arterial injury, and effect of selective Kv1.3 blockade with PAP-1 on intimal hyperplasia formation. Cardiovasc Drugs Ther (2014) 0.76
Electron microscopic identification of parvovirus virions in erythroid and granulocytic-line cells in a patient with human parvovirus B19 induced pancytopenia. Leuk Lymphoma (1993) 0.76
Morphology of hepatic stellate cells in patients with fulminant or subfulminant hepatitis requiring liver transplantation. J Submicrosc Cytol Pathol (1996) 0.76
Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review. J Surg Oncol (1990) 0.76
Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study. J Endocrinol Invest (2010) 0.76